182 related articles for article (PubMed ID: 16246548)
61. Electronic structure, novel synthesis, and O-H...O and C-H...O interactions in two 6-oxopiperidine-2-carboxylic acid derivatives.
Vrábel V; Sivý J; Šafář P; Marchalín Š
Acta Crystallogr C Struct Chem; 2014 Aug; 70(Pt 8):817-22. PubMed ID: 25093366
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of GABA uptake in subcellular fractions of bovine frontal cortex and brainstem.
Höfner G; Wanner KT
Neurosci Lett; 2004 Jun; 364(1):53-7. PubMed ID: 15193755
[TBL] [Abstract][Full Text] [Related]
63. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives by Suzuki-Miyaura Cross-Coupling Reactions.
Petrera M; Wein T; Allmendinger L; Sindelar M; Pabel J; Höfner G; Wanner KT
ChemMedChem; 2016 Mar; 11(5):519-38. PubMed ID: 26683881
[TBL] [Abstract][Full Text] [Related]
64. Novel malonamide derivatives as potent kappa opioid receptor agonists.
Chu GH; Gu M; Cassel JA; Belanger S; Graczyk TM; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2007 Apr; 17(7):1951-5. PubMed ID: 17307360
[TBL] [Abstract][Full Text] [Related]
65. The role of structure activity relationship studies in the search for new GABA uptake inhibitors.
Kulig K; Szwaczkiewicz M
Mini Rev Med Chem; 2008 Oct; 8(12):1214-23. PubMed ID: 18855736
[TBL] [Abstract][Full Text] [Related]
66. Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.
Bonjoch J; Diaba F; Pagès L; Pérez D; Soca L; Miralpeix M; Vilella D; Anton P; Puig C
Bioorg Med Chem Lett; 2009 Aug; 19(15):4299-302. PubMed ID: 19505824
[TBL] [Abstract][Full Text] [Related]
67. Synthesis of new 3-pyridinecarboxylates of potential vasodilation properties.
Girgis AS; Mishriky N; Farag AM; El-Eraky WI; Farag H
Eur J Med Chem; 2008 Sep; 43(9):1818-27. PubMed ID: 18241958
[TBL] [Abstract][Full Text] [Related]
68. Development of New Photoswitchable Azobenzene Based γ-Aminobutyric Acid (GABA) Uptake Inhibitors with Distinctly Enhanced Potency upon Photoactivation.
Lutz T; Wein T; Höfner G; Pabel J; Eder M; Dine J; Wanner KT
J Med Chem; 2018 Jul; 61(14):6211-6235. PubMed ID: 29924931
[TBL] [Abstract][Full Text] [Related]
69. Synthesis of both enantiomers of hydroxypipecolic acid derivatives equivalent to 5-azapyranuronic acids and evaluation of their inhibitory activities against glycosidases.
Yoshimura Y; Ohara C; Imahori T; Saito Y; Kato A; Miyauchi S; Adachi I; Takahata H
Bioorg Med Chem; 2008 Sep; 16(17):8273-86. PubMed ID: 18703340
[TBL] [Abstract][Full Text] [Related]
70. Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.
Zhang YM; Fan X; Xiang B; Chakravarty D; Scannevin R; Burke S; Karnachi P; Rhodes K; Jackson P
Bioorg Med Chem Lett; 2006 Jun; 16(12):3096-100. PubMed ID: 16632358
[TBL] [Abstract][Full Text] [Related]
71. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A; Akula KK; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
[TBL] [Abstract][Full Text] [Related]
72. Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors.
Verissimo E; Berry N; Gibbons P; Cristiano ML; Rosenthal PJ; Gut J; Ward SA; O'Neill PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4210-4. PubMed ID: 18554905
[TBL] [Abstract][Full Text] [Related]
73. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
[TBL] [Abstract][Full Text] [Related]
74. Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation.
Tegley CM; Viswanadhan VN; Biswas K; Frohn MJ; Peterkin TA; Chang C; Bürli RW; Dao JH; Veith H; Rogers N; Yoder SC; Biddlecome G; Tagari P; Allen JR; Hungate RW
Bioorg Med Chem Lett; 2008 Jul; 18(14):3925-8. PubMed ID: 18579373
[TBL] [Abstract][Full Text] [Related]
75. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
[TBL] [Abstract][Full Text] [Related]
76. Design and synthesis of novel metalloproteinase inhibitors.
Nakatani S; Ikura M; Yamamoto S; Nishita Y; Itadani S; Habashita H; Sugiura T; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M
Bioorg Med Chem; 2006 Aug; 14(15):5402-22. PubMed ID: 16621578
[TBL] [Abstract][Full Text] [Related]
77. Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors.
Akritopoulou-Zanze I; Darczak D; Sarris K; Phelan KM; Huth JR; Song D; Johnson EF; Jia Y; Djuric SW
Bioorg Med Chem Lett; 2006 Jan; 16(1):96-9. PubMed ID: 16216502
[TBL] [Abstract][Full Text] [Related]
78. Phenylimidazole derivatives as new inhibitors of bacterial enoyl-ACP reductase FabK.
Kitagawa H; Ozawa T; Takahata S; Iida M
Bioorg Med Chem Lett; 2007 Sep; 17(17):4982-6. PubMed ID: 17600706
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
Alstermark C; Amin K; Dinn SR; Elebring T; Fjellström O; Fitzpatrick K; Geiss WB; Gottfries J; Guzzo PR; Harding JP; Holmén A; Kothare M; Lehmann A; Mattsson JP; Nilsson K; Sundén G; Swanson M; von Unge S; Woo AM; Wyle MJ; Zheng X
J Med Chem; 2008 Jul; 51(14):4315-20. PubMed ID: 18578471
[TBL] [Abstract][Full Text] [Related]
80. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
